Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2321-2330

  Pink, John J ^a   Jordan, V Craig ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; EXON; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; TISSUE DISTRIBUTION;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; DOWN-REGULATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYTESTOSTERONES; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROTEIN BINDING; RECEPTORS, ESTROGEN; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029883292     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Lerner, L. J., and Jordan, V C. Development of antiestrogens and their use in breast cancer. Cancer Res., 50: 4177-4189, 1990.
2. Early Breast Cancer Trialists Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet, 339: 1-14, 1992
3. Jordan, V. C., Collins, M. M., Rowsby, L., and Prestwich, G. A monohydroxylated metabolite of tamoxifen with potent antiestrogenic activity. J Endocrinol., 73: 305-316, 1977
4. Wakeling, A. E , Dukes, M., and Bowler. J A potent specific pure antiestrogen with clinical potential. Cancer Res , 51: 3867-3873, 1991
5. Howell, A., DeFriend, D., Robertson, J , Blamey, R , and Walton, P. Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer Lancet, 345: 29-30, 1995.
6. Jordan, V. C., and Murphy, C. S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev , 11: 578-610, 1990.
7. Cidlowski, J. A., and Muldoon, T. G. Estrogenic regulation of cytoplasmic receptor populations in estrogen-responsive tissues of the rat. Endocrinology, 95. 1621-1629, 1974.
8. Cidlowski, J. A., and Muldoon, T. G. Sex-related differences in the regulation of cytoplasmic estrogen receptor levels in responsive tissues of the rat. Endocrinology, 98: 833-841, 1976.
9. Gorski, J., Stormshak, F., Harris, J., and Wertz, N. Hormone regulation of growth: stimulatory and inhibitory influences of estrogens on DNA synthesis. J. Toxicol. Environ. Health, 3: 271-279, 1977
10. Dickson, R. B., and Eisenfeld, A J. Estrogen receptor in liver of male and female rats: endocrine regulation and molecular properties. Biol. Reprod., 21: 1105-1114, 1979.
11. Lessey, B. A., Wahawisan, R., and Gorell, T. A. Hormonal regulation of cytoplasmic estrogen and progesterone receptors in the beagle uterus and oviduct. Mol. Cell. Endocrinol., 21. 171-80, 1981
12. Norstedt, G., Wrange, O , and Gustafsson, J. A. Multihormonal regulation of the estrogen receptor in rat liver. Endocrinology, 108: 1190-1196, 1981.
13. Eriksson, H A. Different regulation of the concentration of estrogen receptors in the rat liver and uterus following ovariectomy. FEBS Lett., 149: 91-95, 1982.
14. Muldoon, T. G. Steroid hormone receptor regulation by various hormonal factors during mammary development and growth in the normal mouse. Ann. NY Acad. Sci., 464: 17-36, 1986.
15. Saceda, M., Lippman, M. E., Chambon, P., Lindsey, R. L., Ponglikitmongkol, M., Puente, M., and Martin, M. B Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol., 2: 1157-1162, 1988.
16. Berkenstam, A., Glaumann, H , Martin, M., Gustafsson, J. A., and Norstedt, G. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells. Mol Endocrinol., 3: 22-28, 1989.
17. Kiang, D. T., Kollander, R. E., Thomas, T , and Kennedy, B. J. Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer. Cancer Res., 49: 5312-5316, 1989.
18. Read, L. D., Greene, G L., and Katzenellenbogen, B. S. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol. Endocrinol., 3: 295-304, 1989.
19. Shapiro, D. J., Barton, M. C., McKearin, D. M., Chang, T. C., Lew, D., Blume, J., Nielsen, D A., and Gould, L. Estrogen regulation of gene transcription and mRNA stability. Recent Prog. Horm. Res , 45: 29-58, 1989.
20. Shupnik, M. A., Gordon, M S., and Chin, W. W. Tissue-specific regulation of rat estrogen receptor mRNAs. Mol. Endocrinol., 3: 660-665, 1989.
21. Hadcock, J. R., and Malbon, C. C. Regulation of receptor expression by agonists: transcriptional and post-transcriptional controls. Trends Neurosci , 14. 242-247, 1991
22. Medlock, K. L , Lyttle, C. R., Kelepouris, N., Newman, E. D., and Sheehan, D. M. Estradiol down-regulation of the rat uterine estrogen receptor. Proc. Soc. Exp. Biol. Med., 196: 293-300, 1991.
23. Bergman, M. D., Schachter, B S , Karelus, K., Combatsiaris, E P , Garcia, T., and Nelson, J. F. Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiol. Endocrinology, 130. 1923-1930, 1992.
24. Kaneko, K. J., Furlow, J. D., and Gorski, J. Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol. Endocrinol., 7: 879-888, 1993
25. Salbert, G , Atteke, C., Bonnec, G., and Jego, P Differential regulation of the estrogen receptor mRNA by estradiol in the trout hypothalamus and pituitary. Mol. Cell Endocrinol , 96. 177-182, 1993.
26. Zhou, Y., Chorich, L. P , Mahesh, V B , and Ogle, T. F. Regulation of estrogen receptor protein and messenger ribonucleic acid by estradiol and progesterone in rat uterus. J. Steroid Biochem. Mol. Biol., 46: 687-698, 1993.
27. Martin, M. B., Saceda, M., Garcia, M P., and Gottardis, M. M. Regulation of estrogen receptor expression Breast Cancer Res. Treat., 31: 183-189, 1994.
28. Soule, H. D., Vasquez, J., Long, A., Albert, S , and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973
29. Brooks, S. C , Locke, E. R., and Soule, H D Estrogen receptor in a human cell line (MCF-7) from breast carcinoma J. Biol Chem , 248: 6251-6253, 1973.
30. Clarke, R., Skaar, T , Baumann, K , Leonessa, F., James, M., Lippman, J , Thompson, E. W , Freter, C., and Brunner, N. Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res. Treat., 31: 237-248, 1994.
31. Dickson, R. B , and Lippman, M E. Hormonal control of human breast cancer cell lines. Cancer Surv., 5: 617-624, 1986
32. Murphy, C. S., Meisner, L. F , Wu, S. Q., and Jordan, V. C. Short- and long-term estrogen deprivation of T47D human breast cancer cells in culture. Eur. J. Cancer Clin. Oncol., 25: 1777-1788, 1989.
33. Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J , and Berthois, Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res , 47: 4355-4360, 1987.
34. Welshons, W V., and Jordan, V. C. Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture Eur. J. Cancer Clin. Oncol , 23: 1935-1939, 1987
35. Dickson, R. B., and Lippman, M E. Control of human breast cancer by estrogens, growth factors and oncogenes. In: M. E Lippman and R. B. Dickson (eds), Breast Cancer: Cellular and Molecular Biology, pp. 119-166 Boston, MA: Kluwer Academic Publishers, 1988.
36. Dauvois, S., Danielian, P. S., White, R., and Parker, M G. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover Proc Natl. Acad Sci. USA, 89: 4037-4041, 1992.
37. Gibson, M. K , Nemmers, L. A., Beckman, W. J., Davis, V. L., Curtis, S. W., and Korach, K. S. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue Endocrinology, 129: 2000-2010, 1991.
38. Dauvois, S , White, R., and Parker, M. G. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci., 106: 1377-1388, 1993
39. Ree, A. H., Landmark, B. F., Eskild, W., Levy, F O , Lahooti, H., Jahnsen, T., Aakvaag, A., and Hansson, V. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels. Endocrinology, 124. 2577-2583, 1989.
40. Cho, H. S., Ng, P. A., and Katzenellenbogen, B. S. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines Mol. Endocrinol., 5, 1323-1330, 1991.
41. Berthois, Y , Dong, X. F., Roux, D. M., and Martin, P. M. Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: multiparametric analysis of its processing and regulation by estrogen. Mol. Cell. Endocrinol., 74: 11-20, 1990.
42. Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., and Brenner, H. J. Establishment and characterization of a cell line of human breast cancer origin. Eur. J. Cancer, 15: 659-670, 1979
43. Horwitz, K. B., Mockus, M. B., and Lessey, B. A. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell, 28. 633-642, 1982.
44. Karey, K. P., and Sirbasku, D. A. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 β-estradiol. Cancer Res., 48. 4083-4092, 1988.
45. Bowden, R T , Hissom, J R., and Moore, M. R Growth stimulation of T47D human breast cancer cells by the anti-progestin RU486. Endocrinology, 124: 2642-2644, 1989.
46. Graham, M. D., Krett, N. L., Miller, L. A., Leslie, K. K., Gordon, D. F , Wood, W. M., Wei, L L., and Horwitz, K. B T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance. Cancer Res., 50: 6208-6217, 1990.
47. Mullick, A., and Chambon, P. Characterization of the estrogen receptor in two antiestrogen-resistant cell lines. LY2 and T47D Cancer Res., 50: 333-338, 1990.
48. Fernandez, P., Burghardt, R., Smith, R., Nodland, K , and Safe, S. High passage T47D human breast cancer cells, altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness. Eur. J. Pharmacol , 270: 53-65, 1994.
49. Murphy, C. S., Pink, J. J., and Jordan, V. C. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer Res , 50: 7285-7292, 1990.
50. McGuire, W. L., and Clark, G. M. Role of progesterone receptors in breast cancer Semin. Oncol , 12. 12-16, 1985
51. Pink, J. J., Jiang, S. Y , Fritsch, M., and Jordan, V. C An estrogen independent MCF-7 breast cancer cell line which contains a novel 80 kilodalton estrogen receptor related protein Cancer Res , 55: 2583-2590, 1995.
52. LaBarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem., 102: 344-352, 1980.
53. MacGregor, G. R., and Caskey, C. T Construction of plasmids that express E. coli β-gatactosidase in mammalian cells. Nucleic Acids Res., 17. 2365, 1989.
54. Luyten, G. P , Hoogeveen, A. T., and Galjaard, H. A fluorescence staining method for the demonstration and measurement of lysosomal enzyme activities in single cells. J. Histochem. Cytochem., 33: 965-968, 1985.
55. Badley, J E , Bishop, G A., St John, T., and Frelinger, J. A. A simple, rapid method for the purification of poly A + RNA. Biotechniques, 6. 114-116, 1988.
56. Catherino, W. H., and Jordan, V. C. Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue. Cancer Lett., 92: 39-47, 1995.
57. McGuire, W. L. Prognostic factors in primary breast cancer Cancer Surv , 5: 527-536, 1986
58. van den Berg, H , Lynch, M., Martin, J., Nelson, J., Dickson, G. R., and Crockard, A. D. Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype. Br. J Cancer, 59: 522-526, 1989.
59. Langdon, S. P., Ritchie, A., Young, K., Crew, A. J., Sweeting, V., Bramley, T., Hillier, S , Hawkins, R A., Tesdale, A L., and Smyth, J F Contrasting effects of 17 β-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo. Int. J. Cancer, 55: 459-464, 1993.
60. Riegel, A. T., Aitken, S C , Martin, M. B , and Schoenberg, D. R. Differential induction of hepatic estrogen receptor and vitellogenin gene transcription in Xenopus laevis. Endocrinology, 120: 1283-1290, 1987.
61. Slater, E. P , Redeuilh, G., and Beato, M. Hormonal regulation of vitellogenin genes: an estrogen-responsive element in the Xenopus A2 gene and a multihormonal regulatory region in the chicken II gene Mol Endocrinol., 5: 386-396, 1991
62. Fawell, S E., White, R , Hoare, S , Sydenham, M., Page, M., and Parker, M. G. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA, 87: 6883-6887, 1990.
63. Jiang, S Y., Wolf, D. M , Yingling, J M., Chang, C., and Jordan, V C. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Mol Cell. Endocrinol., 90: 77-86, 1992.
64. Brunner, N , Boulay, V , Fojo, A., Freter, C. E., Lippman, M. E., and Clarke, R. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res., 53 283-290, 1993.